Background: Antiphospholipid antibodies (aPLs) are antibodies directed against components of the cell membrane and can be associated with clinical features or be asymptomatic in 1-5% of the population.
Objective: The objective of this study is to investigate the frequency of aPL positivity based on body mass index (BMI).
Methods: This is a retrospective analysis of all aPL testing done in a tertiary center between 2010 and 2020.
Background: Coronavirus disease 19 (COVID-19) vaccination has been established as preventing severe and mortal COVID-19. Vaccination is critical strategy in controlling the COVID-19 pandemic, to restrict infections and reduce disease severity. Vaccination coverage will be more extensive if we can better identify vaccination barriers in the population, especially among vulnerable groups, of which one is pregnant women.
View Article and Find Full Text PDF